Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

Abstract excerpt

BACKGROUND: Antibodies against myelin oligodendrocyte glycoprotein (MOG) have been identified in a subgroup of pediatric patients with inflammatory demyelinating disease of the central nervous system (CNS) and in some patients with neuromyelitis optica spectrum disorder (NMOSD). The aim of this study was to examine the frequency, clinical features, and long-term disease course of patients with anti-MOG antibodies...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Sclerosis Research Studies
• Share to Peripheral Neuropathies and Disorders
• Share to Systemic Lupus Erythematosus Research